Variant report
Variant | nsv9558 |
---|---|
Chromosome Location | chr2:35967774-35998170 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142406045 | chr2:35967782-35967783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576883027 | chr2:35967808-35967809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544888774 | chr2:35967840-35967841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544230787 | chr2:35967853-35967854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11313341 | chr2:35967864-35967865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs397872799 | chr2:35967870-35967871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562404390 | chr2:35967871-35967872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529839349 | chr2:35967891-35967892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189165315 | chr2:35967898-35967899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560328858 | chr2:35967912-35967913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527496750 | chr2:35967986-35967987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552025038 | chr2:35968008-35968009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10654012 | chr2:35968020-35968021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs72476934 | chr2:35968021-35968022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34276587 | chr2:35968022-35968023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570417252 | chr2:35968028-35968029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566944079 | chr2:35968064-35968065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72871363 | chr2:35968074-35968075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550186878 | chr2:35968102-35968103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114146572 | chr2:35968110-35968111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554059001 | chr2:35968173-35968174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145982710 | chr2:35968190-35968191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567667948 | chr2:35968218-35968219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs386644811 | chr2:35968228-35968229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540063134 | chr2:35968281-35968282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs13000629 | chr2:35968310-35968311 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs576818281 | chr2:35968338-35968339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549346520 | chr2:35968343-35968344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138522881 | chr2:35968359-35968360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556192226 | chr2:35968372-35968373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185654188 | chr2:35968391-35968392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149253759 | chr2:35968409-35968410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77826304 | chr2:35968429-35968430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144588799 | chr2:35968463-35968464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545600703 | chr2:35968476-35968477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188846884 | chr2:35968506-35968507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs180887193 | chr2:35968508-35968509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569085266 | chr2:35968526-35968527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549882957 | chr2:35968545-35968546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148474403 | chr2:35968562-35968563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529288500 | chr2:35968578-35968579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115922804 | chr2:35968583-35968584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs13001188 | chr2:35968593-35968594 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs199688162 | chr2:35968638-35968639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557155608 | chr2:35968655-35968656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12477575 | chr2:35968672-35968673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12477576 | chr2:35968675-35968676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114160082 | chr2:35968687-35968688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs578260048 | chr2:35968745-35968746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537778324 | chr2:35968750-35968751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:35963800-35971600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr2:35963800-35972000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
3 | chr2:35971600-35972000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:35972000-35972200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr2:35977000-35977200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:35977200-35980000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr2:35980000-35984600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:35984600-35985000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr2:35985000-35986600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr2:35986600-35987000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr2:35987000-35990600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr2:35990600-35991600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:35997000-36004600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |